Aptamer Group PLC

APTA

Company Profile

  • Business description

    Aptamer Group PLC provides Optimer binders for use in research, diagnostics and therapeutics. It strives to deliver transformational solutions that meet the needs of researchers and developers across the life sciences through the use of its proprietary Optimer technology. Its businesses, Aptamer Solutions for custom Optimer development, Aptamer Diagnostics for in-house and collaborative Optimer-based diagnostic development and Aptamer Therapeutics for the development of Optimer-based therapeutics. The Group represents a single operating segment being research and experimental development of biotechnology. It operates in United Kingdom, Europe, USA and others.

  • Contact

    Innovation Way
    Windmill House
    YorkYO10 5BR
    GBR

    T: +44 1904217404

    E: [email protected]

    https://www.aptamergroup.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    30 June 2026

    Employees

    31

Stocks News & Analysis

stocks

ASX tech share tracking below guidance

Moat Rating downgraded for overvalued shares.
stocks

After plunge ASX blue chip undervalued

This company earns a moat from our analysts.
stocks

Older cohorts the budget losers, not necessarily the ASX listed insurers

Proposed legislation removes health insurance rebates.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,717.0082.40-0.94%
CAC 408,117.42135.661.70%
DAX 4024,737.24336.591.38%
Dow JONES (US)50,009.35645.471.31%
FTSE 10010,432.34101.790.99%
HKSE25,651.12146.73-0.57%
NASDAQ26,270.36399.651.54%
Nikkei 22559,804.41746.18-1.23%
NZX 50 Index12,761.03213.29-1.64%
S&P 5007,432.9779.361.08%
S&P/ASX 2008,496.6076.50-0.89%
SSE Composite Index4,162.187.35-0.18%

Market Movers